✦ LIBER ✦

Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B

✍ Scribed by S. G. LIM; N. LEUNG; H. W. L. HANN; G. K. K. LAU; C. TREPO; H. MOMMEJA-MARIN; C. MOXHAM; J. SORBEL; A. SNOW; M. R. BLUM; F. ROUSSEAU; P. MARCELLIN

Book ID: 108605316
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 181 KB
Volume: 27
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2008.03686.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiviral activity, dose–response relati

Antiviral activity, dose–response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial

✍ Michiko Shindo; Kazuaki Chayama; Satoshi Mochida; Joji Toyota; Eiichi Tomita; Hi 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 242 KB

Efficacy and safety of entecavir compare

Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China

✍ Guangbi Yao; Chengwei Chen; Weilun Lu; Hong Ren; Deming Tan; Yuming Wang; Daozhe 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 223 KB

Efficacy and safety of entecavir compare

Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China

✍ Guangbi Yao; Chengwei Chen; Weilun Lu; Hong Ren; Deming Tan; Yuming Wang; Daozhe 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 89 KB